Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Akero Therapeutics, Inc. (AKRO)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
27 Dec 2023
Young Jonathan
Chief Operating Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
185,131
-2%
5,414
$24.00
$129,936.00
SELL
14 Dec 2023
Rolph Timothy
Chief Scientific Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
182,672
-0%
514
$20.76
$10,670.64
SELL
14 Dec 2023
Cheng Andrew
President and CEO, Director, Officer
Akero Therapeutics, Inc.
(AKRO)
550,911
-0%
1,628
$20.76
$33,797.28
SELL
14 Dec 2023
White William Richard
Chief Financial Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
50,354
-1%
611
$20.76
$12,684.36
SELL
14 Dec 2023
Young Jonathan
Chief Operating Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
185,131
-0%
543
$20.76
$11,272.68
SELL
14 Dec 2023
Yale Catriona
Chief Development Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
77,910
-0%
597
$20.76
$12,393.72
SELL
13 Sep 2023
Young Jonathan
Chief Operating Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
183,177
-0%
562
$50.34
$28,291.08
SELL
13 Sep 2023
Yale Catriona
Chief Development Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
48,210
-10%
5,617
$48.32
$271,415.80
SELL
13 Sep 2023
Rolph Timothy
Chief Scientific Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
150,689
-0%
531
$50.34
$26,730.54
SELL
13 Sep 2023
White William Richard
Chief Financial Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
18,468
-3%
632
$50.34
$31,814.88
SELL
13 Sep 2023
Cheng Andrew
President and CEO, Director, Officer
Akero Therapeutics, Inc.
(AKRO)
460,998
-0%
1,682
$50.34
$84,671.88
SELL
1 Sep 2023
Cheng Andrew
President and CEO, Director, Officer
Akero Therapeutics, Inc.
(AKRO)
462,807
-5%
25,000
$49.77
$1,244,247.60
SELL
28 Aug 2023
Yale Catriona
Chief Development Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
47,127
-10%
5,745
$49.99
$287,190.56
BUY
8 Aug 2023
Graham G. Walmsley
Director
Akero Therapeutics, Inc.
(AKRO)
600,000
+4%
25,000
$42.06
$1,051,475.00
SELL
1 Aug 2023
Cheng Andrew
President and CEO, Director, Officer
Akero Therapeutics, Inc.
(AKRO)
459,001
-5%
25,000
$43.15
$1,078,866.60
BUY
28 Jul 2023
Graham G. Walmsley
Director
Akero Therapeutics, Inc.
(AKRO)
575,000
+10%
55,000
$42.95
$2,362,234.00
SELL
3 Jul 2023
Cheng Andrew
President and CEO, Director, Officer
Akero Therapeutics, Inc.
(AKRO)
453,950
-5%
25,000
$44.88
$1,122,041.00
SELL
21 Jun 2023
Yale Catriona
Chief Development Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
47,127
-41%
33,349
$51.74
$1,725,390.10
SELL
20 Jun 2023
White William Richard
Chief Financial Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
19,100
-52%
20,777
$55.00
$1,142,735.00
SELL
16 Jun 2023
Henderson Jane
Director
Akero Therapeutics, Inc.
(AKRO)
22,498
-64%
40,000
$54.17
$2,166,684.80
SELL
16 Jun 2023
Rolph Timothy
Chief Scientific Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
180,095
-30%
78,200
$54.78
$4,284,066.00
SELL
16 Jun 2023
Heyman Tomas J.
Director
Akero Therapeutics, Inc.
(AKRO)
0
-100%
26,000
$54.67
$1,421,529.10
SELL
13 Jun 2023
Yale Catriona
Chief Development Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
79,976
-0%
591
$55.16
$32,599.56
SELL
13 Jun 2023
Rolph Timothy
Chief Scientific Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
189,420
-0%
509
$55.16
$28,076.44
SELL
13 Jun 2023
Young Jonathan
Chief Operating Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
183,739
-0%
538
$55.16
$29,676.08
SELL
13 Jun 2023
Cheng Andrew
President & CEO, Director, Officer
Akero Therapeutics, Inc.
(AKRO)
407,680
-0%
1,613
$55.16
$88,973.08
SELL
13 Jun 2023
White William Richard
Chief Financial Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
22,377
-2%
606
$55.16
$33,426.96
SELL
1 Jun 2023
Cheng Andrew
President and CEO, Director, Officer
Akero Therapeutics, Inc.
(AKRO)
430,379
-5%
25,000
$45.10
$1,127,430.20
SELL
18 Apr 2023
Cheng Andrew
President & CEO, Director, Officer
Akero Therapeutics, Inc.
(AKRO)
412,770
-5%
25,000
$45.07
$1,126,859.60
SELL
3 Apr 2023
Cheng Andrew
President & CEO, Director, Officer
Akero Therapeutics, Inc.
(AKRO)
371,001
-6%
25,000
$37.94
$948,576.00
SELL
1 Mar 2023
Cheng Andrew
President & CEO, Director, Officer
Akero Therapeutics, Inc.
(AKRO)
393,734
-5%
25,000
$46.65
$1,166,338.50
SELL
1 Feb 2023
Cheng Andrew
President & CEO, Director, Officer
Akero Therapeutics, Inc.
(AKRO)
381,154
-6%
25,000
$49.06
$1,226,395.20
SELL
13 Jan 2023
Yale Catriona
Chief Development Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
85,220
-5%
5,000
$50.53
$252,650.69
SELL
3 Jan 2023
Young Jonathan
Chief Operating Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
184,911
-4%
8,777
$54.64
$479,560.38
SELL
3 Jan 2023
Cheng Andrew
President & CEO, Director, Officer
Akero Therapeutics, Inc.
(AKRO)
382,799
-6%
25,000
$51.27
$1,281,751.10
SELL
28 Dec 2022
Rolph Timothy
Chief Scientific Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
202,825
-9%
22,016
$50.97
$1,122,125.20
SELL
27 Dec 2022
Young Jonathan
Chief Operating Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
182,449
-6%
12,500
$49.57
$619,608.75
SELL
27 Dec 2022
White William Richard
Chief Financial Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
23,624
-45%
20,000
$49.77
$995,323.25
SELL
9 Dec 2022
Yale Catriona
Chief Development Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
86,670
-5%
5,000
$43.23
$216,137.19
SELL
1 Dec 2022
Cheng Andrew
President & CEO, Director, Officer
Akero Therapeutics, Inc.
(AKRO)
310,148
-3%
10,000
$46.07
$460,700.00
SELL
1 Dec 2022
Skorpios Trust
Former 10% owner
Akero Therapeutics, Inc.
(AKRO)
3,271,829
-33%
1,636,000
$43.50
$71,166,000.00
SELL
30 Nov 2022
Harrison Seth Loring
Director
Akero Therapeutics, Inc.
(AKRO)
141,080
-14%
23,131
$46.94
$1,085,739.50
SELL
15 Nov 2022
Rolph Timothy
Chief Scientific Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
183,937
-3%
7,085
$45.28
$320,806.47
SELL
10 Nov 2022
Yale Catriona
Chief Development Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
72,173
-6%
5,000
$39.42
$197,105.00
BUY
8 Nov 2022
Christopher L. Jacobs
Congressman (House)
Akero Therapeutics, Inc.
(AKRO)
N/A
N/A
N/A
$1,001 - $15,000
SELL
1 Nov 2022
Cheng Andrew
President & CEO, Director, Officer
Akero Therapeutics, Inc.
(AKRO)
319,548
-3%
10,000
$43.42
$434,183.00
SELL
28 Oct 2022
Harrison Seth Loring
Director
Akero Therapeutics, Inc.
(AKRO)
148,202
-22%
44,103
$40.31
$1,777,829.00
SELL
25 Oct 2022
Young Jonathan
Chief Operating Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
163,254
-7%
12,500
$44.72
$558,943.75
SELL
25 Oct 2022
Rolph Timothy
Chief Scientific Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
190,922
-7%
15,415
$45.07
$694,781.94
SELL
25 Oct 2022
Harrison Seth Loring
Director
Akero Therapeutics, Inc.
(AKRO)
194,063
-59%
285,487
$42.71
$12,193,196.00
SELL
13 Oct 2022
White William Richard
Chief Financial Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
4,429
-81%
20,000
$39.82
$796,400.00
SELL
10 Oct 2022
Yale Catriona
Chief Development Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
77,073
-6%
5,000
$37.99
$189,950.02
SELL
6 Oct 2022
Rolph Timothy
Chief Scientific Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
186,337
-10%
22,500
$39.29
$884,025.00
SELL
3 Oct 2022
Cheng Andrew
President & CEO, Director, Officer
Akero Therapeutics, Inc.
(AKRO)
315,598
-3%
10,000
$33.23
$332,278.50
SELL
30 Sep 2022
Rolph Timothy
Chief Scientific Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
221,337
-16%
45,000
$32.72
$1,472,400.00
BUY
19 Sep 2022
Graham G. Walmsley
Director
Akero Therapeutics, Inc.
(AKRO)
400,000
+433%
520,000
$29.69
$15,440,000.00
BUY
19 Sep 2022
Graham G. Walmsley
Director
Akero Therapeutics, Inc.
(AKRO)
520,000
+100%
520,000
$29.69
$15,440,000.00
SELL
13 Sep 2022
Yale Catriona
Chief Development Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
96,059
-29%
40,000
$27.48
$1,099,228.00
SELL
13 Sep 2022
White William Richard
Chief Financial Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
18,009
-64%
32,500
$27.03
$878,341.00
SELL
13 Sep 2022
Rolph Timothy
Chief Scientific Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
223,837
-9%
22,500
$29.18
$656,550.00
SELL
13 Sep 2022
Cheng Andrew
President & CEO, Director, Officer
Akero Therapeutics, Inc.
(AKRO)
353,352
-14%
60,000
$27.42
$1,645,443.80
SELL
13 Sep 2022
Rolph Timothy
Chief Scientific Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
233,837
-8%
22,500
$29.18
$656,550.00
SELL
1 Mar 2022
Cheng Andrew
President & CEO, Director, Officer
Akero Therapeutics, Inc.
(AKRO)
308,996
-3%
10,000
$17.59
$175,900.00
SELL
1 Feb 2022
Cheng Andrew
President & CEO, Director, Officer
Akero Therapeutics, Inc.
(AKRO)
308,996
-3%
10,000
$17.56
$175,600.00
SELL
14 Jan 2022
White William Richard
Chief Financial Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
3,277
-74%
9,700
$22.03
$213,691.00
SELL
10 Jan 2022
Cheng Andrew
President & CEO, Director, Officer
Akero Therapeutics, Inc.
(AKRO)
298,996
-3%
10,000
$19.55
$195,500.00
SELL
21 Dec 2021
White William Richard
Chief Financial Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
3,277
-2%
100
$22.00
$2,200.00
SELL
17 Dec 2021
White William Richard
Chief Financial Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
3,277
-49%
3,200
$22.04
$70,528.00
SELL
2 Dec 2021
Cheng Andrew
President & CEO, Director, Officer
Akero Therapeutics, Inc.
(AKRO)
255,996
-6%
17,500
$20.18
$353,150.00
SELL
3 Nov 2021
Young Jonathan
Chief Operating Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
135,510
-15%
25,000
$24.28
$607,123.20
SELL
2 Nov 2021
Cheng Andrew
President & CEO, Director, Officer
Akero Therapeutics, Inc.
(AKRO)
273,496
-6%
17,500
$22.57
$394,975.00
SELL
1 Nov 2021
White William Richard
Chief Financial Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
3,277
-66%
6,500
$22.24
$144,560.00
SELL
15 Oct 2021
Yale Catriona
Chief Development Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
121,021
-9%
12,500
$21.59
$269,826.00
SELL
4 Oct 2021
Cheng Andrew
President & CEO, Director, Officer
Akero Therapeutics, Inc.
(AKRO)
290,996
-5%
17,500
$21.54
$376,950.03
SELL
1 Oct 2021
White William Richard
Chief Financial Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
3,277
-66%
6,500
$22.06
$143,366.61
SELL
15 Sep 2021
Yale Catriona
Chief Development Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
135,421
-8%
12,500
$24.69
$308,605.00
SELL
2 Sep 2021
Cheng Andrew
President & CEO, Director, Officer
Akero Therapeutics, Inc.
(AKRO)
308,496
-5%
17,500
$23.89
$418,075.00
SELL
1 Sep 2021
Young Jonathan
Chief Operating Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
160,510
-7%
12,500
$24.04
$300,500.00
SELL
1 Sep 2021
White William Richard
Chief Financial Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
3,277
-72%
8,559
$24.00
$205,416.00
SELL
16 Aug 2021
Yale Catriona
Chief Development Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
145,921
-6%
10,000
$18.79
$187,900.02
SELL
3 Aug 2021
Cheng Andrew
President & CEO, Director, Officer
Akero Therapeutics, Inc.
(AKRO)
326,596
-5%
17,500
$20.83
$364,577.00
SELL
2 Aug 2021
White William Richard
Chief Financial Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
3,277
-57%
4,441
$22.03
$97,835.23
SELL
15 Jul 2021
Yale Catriona
Chief Development Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
155,921
-6%
10,000
$20.90
$209,044.00
SELL
6 Jul 2021
White William Richard
Chief Financial Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
3,277
-66%
6,500
$24.52
$159,380.00
SELL
2 Jul 2021
Cheng Andrew
President & CEO, Director, Officer
Akero Therapeutics, Inc.
(AKRO)
342,489
-4%
17,500
$24.78
$433,650.00
SELL
1 Jun 2021
Bitterman Kevin
Director
Akero Therapeutics, Inc.
(AKRO)
0
-100%
17,489
$26.28
$459,610.94
SELL
1 Jun 2021
Young Jonathan
Chief Operating Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
164,010
-1%
3,055
$26.24
$80,150.98
SELL
3 May 2021
Young Jonathan
Chief Operating Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
167,065
-1%
3,055
$30.56
$93,360.80
SELL
3 May 2021
White William Richard
Chief Financial Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
2,270
-64%
4,200
$30.56
$128,352.00
SELL
1 Apr 2021
Young Jonathan
Chief Operating Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
170,120
-1%
3,055
$28.75
$87,827.59
SELL
1 Apr 2021
White William Richard
Chief Financial Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
3,419
-93%
50,000
$28.64
$1,432,166.40
SELL
1 Mar 2021
Young Jonathan
Chief Operating Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
173,375
-1%
3,055
$30.48
$93,111.65
SELL
1 Feb 2021
Young Jonathan
Chief Operating Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
176,430
-1%
3,055
$29.24
$89,321.45
SELL
7 Jan 2021
Young Jonathan
Chief Operating Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
179,285
-5%
10,000
$28.12
$281,200.00
SELL
4 Jan 2021
Young Jonathan
Chief Operating Officer, Officer
Akero Therapeutics, Inc.
(AKRO)
181,885
-1%
3,060
$25.29
$77,399.20
SELL
9 Oct 2020
Bitterman Kevin
Director
Akero Therapeutics, Inc.
(AKRO)
11,780
-52%
13,000
$28.93
$376,090.00
BUY
10 Jul 2020
Harrison Seth Loring
Director, 10% Owner
Akero Therapeutics, Inc.
(AKRO)
5,830,203
+7%
415,000
$36.00
$14,940,000.00
BUY
10 Jul 2020
Apple Tree Partners IV, L.P.
10% Owner
Akero Therapeutics, Inc.
(AKRO)
5,830,203
+7%
415,000
$36.00
$14,940,000.00
SELL
1 Jul 2020
venBio Global Strategic Fund II L.P.
10% Owner
Akero Therapeutics, Inc.
(AKRO)
3,033,552
-3%
116,467
$34.40
$4,006,537.00
SELL
4 Mar 2020
venBio Global Strategic Fund II L.P.
10% Owner
Akero Therapeutics, Inc.
(AKRO)
3,150,019
-1%
45,950
$23.76
$1,091,607.80
SELL
28 Feb 2020
venBio Global Strategic Fund II L.P.
10% Owner
Akero Therapeutics, Inc.
(AKRO)
3,195,969
-0%
21,798
$22.63
$493,310.25
SELL
25 Feb 2020
venBio Global Strategic Fund II L.P.
10% Owner
Akero Therapeutics, Inc.
(AKRO)
3,227,767
-0%
5,904
$22.80
$134,635.10
SELL
11 Feb 2020
venBio Global Strategic Fund II L.P.
10% Owner
Akero Therapeutics, Inc.
(AKRO)
3,233,671
-0%
10,026
$27.07
$271,399.20
SELL
6 Feb 2020
venBio Global Strategic Fund II L.P.
10% Owner
Akero Therapeutics, Inc.
(AKRO)
3,233,697
-0%
6,102
$27.03
$164,954.75
SELL
4 Feb 2020
venBio Global Strategic Fund II L.P.
10% Owner
Akero Therapeutics, Inc.
(AKRO)
3,239,799
-2%
82,339
$25.77
$2,121,726.20
SELL
16 Jan 2020
Versant Venture Capital VI, L.P.
10% Owner
Akero Therapeutics, Inc.
(AKRO)
3,110,547
-1%
59,532
$20.87
$1,242,403.40
SELL
13 Jan 2020
venBio Global Strategic Fund II L.P.
10% Owner
Akero Therapeutics, Inc.
(AKRO)
3,322,138
-12%
494,000
$20.23
$9,993,620.00
SELL
10 Jan 2020
Versant Venture Capital VI, L.P.
10% Owner
Akero Therapeutics, Inc.
(AKRO)
3,152,230
-1%
50,837
$20.04
$1,018,571.00
SELL
8 Jan 2020
venBio Global Strategic Fund II L.P.
10% Owner
Akero Therapeutics, Inc.
(AKRO)
3,816,138
-0%
15,677
$19.86
$311,354.62
SELL
7 Jan 2020
Versant Venture Capital VI, L.P.
10% Owner
Akero Therapeutics, Inc.
(AKRO)
3,203,067
-1%
53,057
$19.99
$1,060,845.10
SELL
6 Jan 2020
venBio Global Strategic Fund II L.P.
10% Owner
Akero Therapeutics, Inc.
(AKRO)
3,831,815
-1%
73,221
$19.86
$1,454,530.00
SELL
2 Jan 2020
Versant Venture Capital VI, L.P.
10% Owner
Akero Therapeutics, Inc.
(AKRO)
3,304,548
-2%
72,444
$19.70
$1,427,272.20
SELL
2 Jan 2020
venBio Global Strategic Fund II L.P.
10% Owner
Akero Therapeutics, Inc.
(AKRO)
3,905,036
-0%
35,498
$19.71
$699,721.20
SELL
31 Dec 2019
venBio Global Strategic Fund II L.P.
10% Owner
Akero Therapeutics, Inc.
(AKRO)
3,940,534
-0%
14,324
$23.96
$343,258.90
SELL
27 Dec 2019
Versant Venture Capital VI, L.P.
10% Owner
Akero Therapeutics, Inc.
(AKRO)
3,656,585
-9%
389,382
$24.20
$9,421,174.00
SELL
20 Dec 2019
Versant Venture Capital VI, L.P.
10% Owner
Akero Therapeutics, Inc.
(AKRO)
4,045,967
-1%
49,220
$21.34
$1,050,415.50
SELL
17 Dec 2019
Versant Venture Capital VI, L.P.
10% Owner
Akero Therapeutics, Inc.
(AKRO)
4,095,187
-0%
9,671
$19.56
$189,196.58
BUY
24 Jun 2019
Harrison Seth Loring
Director, 10% Owner
Akero Therapeutics, Inc.
(AKRO)
5,415,203
+19%
900,000
$16.00
$14,400,000.00
BUY
24 Jun 2019
Atlas Venture Fund XI, L.P.
10% Owner
Akero Therapeutics, Inc.
(AKRO)
505,099
+114%
270,000
$16.00
$4,320,000.00
BUY
24 Jun 2019
Versant Venture Capital VI, L.P.
10% Owner
Akero Therapeutics, Inc.
(AKRO)
4,104,858
+10%
400,000
$16.00
$6,400,000.00
BUY
24 Jun 2019
Bitterman Kevin
Director
Akero Therapeutics, Inc.
(AKRO)
505,099
+114%
270,000
$16.00
$4,320,000.00
BUY
24 Jun 2019
Royston Aaron
Director
Akero Therapeutics, Inc.
(AKRO)
250,000
+100%
250,000
$16.00
$4,000,000.00
BUY
24 Jun 2019
Apple Tree Partners IV, L.P.
10% Owner
Akero Therapeutics, Inc.
(AKRO)
5,415,203
+19%
900,000
$16.00
$14,400,000.00
BUY
24 Jun 2019
venBio Global Strategic Fund II L.P.
10% Owner
Akero Therapeutics, Inc.
(AKRO)
250,000
+100%
250,000
$16.00
$4,000,000.00
Home